Breast Imaging: Page 20

FDA clears Therapixel mammo AI software for tomosynthesis

By AuntMinnie.com staff writers

French artificial intelligence (AI) software developer Therapixel's MamoScreen software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with digital breast tomosynthesis.

November 27, 2021

QView software to launch from GE's ABUS scanner

By AuntMinnie.com staff writers

Software from computer-aided detection (CAD) software developer QView Medical can now be launched from GE Healthcare's automated breast ultrasound (ABUS) scanner, the Invenia ABUS 2.0.

November 22, 2021

Breast MRI shows effects of IUDs on body

By Amerigo Allegretto

Breast MRI shows that intrauterine contraceptive devices (IUDs) have systemic effects on the body and not just the uterus. The phenomenon could affect the accuracy of breast MRI, according to research being presented at the RSNA 2021 annual meeting.

November 21, 2021

'Plug-and-play' AI method helps with microcalcifications on DBT

By Amerigo Allegretto

Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSPH09-6 | Room S405Researchers will present results from a "plug-and-play" artificial intelligence (AI) algorithm that they say has the potential to improve detection of microcalcifications on digital breast tomosynthesis (DBT) images.

November 21, 2021

Koios secures Canada clearance for AI breast ultrasound software

By AuntMinnie.com staff writers

Health Canada has cleared Koios Medical's artificial intelligence (AI) breast ultrasound software.

November 15, 2021

DBT can help evaluate cases of focal breast pain

By Amerigo Allegretto

Digital breast tomosynthesis (DBT) may be useful for evaluating patients with focal breast pain, helping determine whether pain is caused by malignant or benign abnormalities, according to research published November 14 in Clinical Imaging.

November 15, 2021

Road to RSNA 2021: Women's Imaging Preview

By Amerigo Allegretto

At RSNA 2021, attendees will have the chance to learn about new and improved ways to detect and diagnose breast cancers, screening methods that combine multiple imaging modalities, the role of artificial intelligence in reducing false positives and improving accuracy, the continued emergence of digital breast tomosynthesis, abbreviated breast MRI, and more.

November 15, 2021

AI model shows promise in detecting lesions from DBT data

By Amerigo Allegretto

Wednesday, December 1 | 3:00 p.m.-4:00 p.m. | SSBR09-3 | Room TBAFinish your RSNA week off right with this presentation, in which researchers will discuss an artificial intelligence (AI) algorithm that detects lesions using datasets from digital breast tomosynthesis (DBT) exams.

November 15, 2021

'Plug-and-play' AI method helps with microcalcifications on DBT

By Amerigo Allegretto

Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSPH09-6 | Room TBAResearchers will present results from a "plug-and-play" artificial intelligence (AI) algorithm that they say has the potential to improve detection of microcalcifications on digital breast tomosynthesis (DBT) images.

November 15, 2021

AI reduces false positives on breast ultrasound

By Amerigo Allegretto

Monday, November 29 | 3:00 p.m.-4:00 p.m. | SSBR04-6 | Room TBAResearchers will present their findings from a clinical trial that used artificial intelligence (AI) in an effort to reduce false positives on breast ultrasound.

November 15, 2021

DBT continues to show promise a decade after commercial availability

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSBR01-2 | Room TBAPresenters will give the verdict on whether digital breast tomosynthesis (DBT) has been a successful screening method since the first commercially available system was released in 2011.

November 15, 2021

Pandemic affected DBT recall, false-positive rates

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSBR01-6 | Room TBAIn this Sunday presentation, researchers will discuss the results of a study measuring how the COVID-19 pandemic affected recall and false-positive rates for digital breast tomosynthesis (DBT) and digital mammography.

November 15, 2021

Previous Page

Page 20 of 89

Next Page